newsfilter
← Latest News
PR Newswire·

Luminex Receives BARDA Contract to Support Development of Second, Rapid SARS-CoV-2 Test

Luminex Corporation (NASDAQ: LMNX) today announced that it has received $642,450 in funding from the Biomedical Advanced Research and Development...